IQVIA electronic Clinical Outcome Assessment (eCOA)

The IQVIA electronic Clinical Outcome Assessment (eCOA) solution bridges the gap between data complexity and operational efficiency in clinical trials. It provides an advanced platform that enhances data quality, patient compliance, and accelerates decision-making by capturing real-time patient-reported data. The eCOA solution includes automated regulatory documentation, streamlined workflows, and offers significant reductions in implementation timelines by up to 75%.

Designed to meet the evolving demands of clinical research, the IQVIA eCOA solution combines scientific credibility with global scalability and digital innovation. It supports high-quality, regulatory-ready data collection through a patient-centric approach. The platform facilitates diary creation with an intuitive drag-and-drop interface, minimizing development timelines and costs while ensuring regulatory compliance.

Key Features:

• Intuitive Design: The IQVIA Sculptor simplifies diary creation with a visual interface, reducing reliance on complex programming and enabling quick customization and previews.
• Patient-Centric Experience: The IQVIA Scribe App offers a user-friendly experience, supports multiple languages, and includes accessibility features to enhance patient engagement and compliance.
• Efficiency and Globalization: The eCOA Library accelerates study start-up by providing access to pre-validated, protocol-ready assessments, ensuring regulatory compliance and global consistency.
• Increased Compliance: Achieves high compliance rates through smart technology that supports patients’ daily routines with features like automated prompts and offline capabilities.

IQVIA eCOA not only supports flexibility with Bring Your Own Device (BYOD) strategies but also provides robust training and robust data collection capabilities, enhancing trial outcomes while ensuring participant engagement and data integrity. The solution is tailored for various therapeutic areas, ensuring alignment with specific study objectives and maximizing the impact of clinical trials.